tert-butyl (8S,11R,12S)-11-[[4-(3,5-dichlorophenyl)phenyl]methyl]-8-[(2-morpholin-4-yl-2-oxoethyl)carbamoyl]-2,10-dioxo-1-oxa-3,9-diazacyclopentadecane-12-carboxylate | 1026605-17-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: tert-butyl (8S,11R,12S)-11-[[4-(3,5-dichlorophenyl)phenyl]methyl]-8-[(2-morpholin-4-yl-2-oxoethyl)carbamoyl]-2,10-dioxo-1-oxa-3,9-diazacyclopentadecane-12-carboxylate
• CAS: 1026605-17-3
• 化学式: C₃₇H₄₈Cl₂N₄O₈
• 分子量: 747.716
• InChiKey: MXLWHBPTNQMYQF-YPKYBTACSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  51
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  152
• 氢给体数：
  3
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  tert-butyl (8S,11R,12S)-11-[[4-(3,5-dichlorophenyl)phenyl]methyl]-8-[(2-morpholin-4-yl-2-oxoethyl)carbamoyl]-2,10-dioxo-1-oxa-3,9-diazacyclopentadecane-12-carboxylate 在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成
  参考文献：
  名称：

  Discovery of Macrocyclic Hydroxamic Acids Containing Biphenylmethyl Derivatives at P1‘, a Series of Selective TNF-α Converting Enzyme Inhibitors with Potent Cellular Activity in the Inhibition of TNF-α Release

  摘要：

  SAR exploration at P1' using an anti-succinate-based macrocyclic hydroxamic acid as a template led to the identification of several bulky biphenylmethyl P1' derivatives which confer potent porcine TACE and anti-TNF-alpha cellular activities with high selectivity versus most of the MMPs screened. Our studies demonstrate for the first time that TACE has a larger S1' pocket in comparison to MMPs and that potent and selective TACE inhibitors can be achieved by incorporation of sterically bulky P1' residues.

  DOI：

  10.1021/jm0155502
• 作为产物：
  描述：

  3-[4-(苄氧基)苯基]丙酸 在 palladium on activated charcoal N-甲基吗啉 、 lithium hydroxide 、 9-borabicyclo[3.3.1]nonane dimer 、 四(三苯基膦)钯 、 正丁基锂 、 氢气 、 双氧水 、 氯化二乙基铝 、 三甲基乙酰氯 、 potassium carbonate 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 二异丙胺 、 N,N-二异丙基乙胺 、 potassium bromide 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 氯仿 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 17.0h， 生成 tert-butyl (8S,11R,12S)-11-[[4-(3,5-dichlorophenyl)phenyl]methyl]-8-[(2-morpholin-4-yl-2-oxoethyl)carbamoyl]-2,10-dioxo-1-oxa-3,9-diazacyclopentadecane-12-carboxylate
  参考文献：
  名称：

  Discovery of Macrocyclic Hydroxamic Acids Containing Biphenylmethyl Derivatives at P1‘, a Series of Selective TNF-α Converting Enzyme Inhibitors with Potent Cellular Activity in the Inhibition of TNF-α Release

  摘要：

  SAR exploration at P1' using an anti-succinate-based macrocyclic hydroxamic acid as a template led to the identification of several bulky biphenylmethyl P1' derivatives which confer potent porcine TACE and anti-TNF-alpha cellular activities with high selectivity versus most of the MMPs screened. Our studies demonstrate for the first time that TACE has a larger S1' pocket in comparison to MMPs and that potent and selective TACE inhibitors can be achieved by incorporation of sterically bulky P1' residues.

  DOI：

  10.1021/jm0155502

文献信息

• Discovery of Macrocyclic Hydroxamic Acids Containing Biphenylmethyl Derivatives at P1‘, a Series of Selective TNF-α Converting Enzyme Inhibitors with Potent Cellular Activity in the Inhibition of TNF-α Release
  作者：Chu-Biao Xue、Xiaohua He、Ronald L. Corbett、John Roderick、Zelda R. Wasserman、Rui-Qin Liu、Bruce D. Jaffee、Maryanne B. Covington、Mingxin Qian、James M. Trzaskos、Robert C. Newton、Ronald L. Magolda、Ruth R. Wexler、Carl P. Decicco

  DOI：10.1021/jm0155502

  日期：2001.10.1

  SAR exploration at P1' using an anti-succinate-based macrocyclic hydroxamic acid as a template led to the identification of several bulky biphenylmethyl P1' derivatives which confer potent porcine TACE and anti-TNF-alpha cellular activities with high selectivity versus most of the MMPs screened. Our studies demonstrate for the first time that TACE has a larger S1' pocket in comparison to MMPs and that potent and selective TACE inhibitors can be achieved by incorporation of sterically bulky P1' residues.